47th Annual Meeting and Exposition
December 10-13, 2005

Georgia World Congress Center
Atlanta, Georgia

Meet-the-Expert Sessions

Duplication/recording is prohibited.

Saturday, December 10, and Sunday, December 11
6:30 – 7:30 am

This year, ASH has scheduled a total of 46 experts from all over the world who will facilitate informal discussions allowing participants to present their questions and gain new perspectives.

Ticket Prices
Fees to attend this year’s sessions are as follows:

ASH Members and ASH Associate Members: $10
Non-Members: $20

These tickets are very limited and are only available on site on a first-come, first-served basis. Please note that the Meet-the-Expert sessions are restricted to registered medical professionals only. No businesspersons or media will be admitted. These tickets can be purchased at the Meet-the-Expert counter in the ASH registration area of the convention center starting Thursday, December 8, during the registration hours until all tickets are sold. Only one ticket per person is allowed. Each room assignment will be indicated on the ticket. Please check your ticket carefully to ensure proper date, time, location, and session choice.

A continental breakfast will be served at 6:15 am both mornings, and the program will begin promptly at 6:30 am.

ATTENTION FELLOWS!
As ASH encourages fellows to participate in these sessions, a number of tickets will be reserved just for fellows. Proof of status as an ASH Associate member or non-member in training will be required to purchase a ticket. Please show your name badge to the staff at the Meet-the-Expert ticket counter.

Saturday, December 10, 6:30 – 7:30 am

BARBARA M. ALVING, MD
National Center for Research Resources, National Institutes of Health, Bethesda, MD
Risks and Management of Thrombosis in Pregnancy and with Hormone-Replacement Therapy

A. JOHN BARRETT, MD, FRCP
National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD
Non-Myeloablative Allogeneic BMT

MOREY A. BLINDER, MD
Washington University, St. Louis, MO
Management of Bleeding Emergencies

ELISABETH M. CRAMER, MD, PHD
Hôpital Ambroise-Paré, Boulogne-Billancourt, France
Megakaryocyte and Platelet Development

DAVID C. DALE, MD
University of Washington, Seattle, WA
Chronic Neutropenia

WALTER H. DZIK, MD
Massachusetts General Hospital, Brookline, MA
Clinical Transfusion Medicine: Surgical Hemostasis and More

CONNIE J. EAVES, PHD
Terry Fox Laboratory, Vancouver, British Columbia, Canada
Hematopoietic Stem Cells: Characterization and Regulation

JAMES N. GEORGE, MD
University of Oklahoma Health Sciences Center, Oklahoma City, OK
ITP/TTP

TERRY GERNSHEIMER, MD
Puget Sound Blood Center and University of Washington School of Medicine, Seattle, WA
Careers in Transfusion Medicine

JEAN-LUC HAROUSSEAU, MD
Hotel Dieu, Nantes, France
Front-Line Therapy of Multiple Myeloma

CATHERINE P.M. HAYWARD, MD, PHD
McMaster University, Hamilton Health Sciences, and St. Joseph's Healthcare, Hamilton, Ontario, Canada
Evaluation and Management of Mild Bleeding Disorders

MICHELLE M. LE BEAU, PHD
University of Chicago, Chicago, IL
Recurring Cytogenetic Abnormalities in Hematologic Malignancies

STEVEN R. LENTZ, MD, PHD
University of Iowa, Iowa City, IA
Homocysteine: Physiology and Clinical Relevance

JEFFREY MCCULLOUGH, MD
University of Minnesota, Minneapolis, MN
The Appropriate Use of Platelet Transfusions

CHARLOTTE MARIE NIEMEYER, MD
University Children's Hospital, Freiburg, Germany
Juvenile Myelomonocytic Leukemia

ALAN T. NURDEN, PHD
CHU Bordeaux, Hôpital Cardiologique, Pessac, France
Inherited Platelet Disorders

LESLIE V. PARISE, PHD
University of North Carolina, Chapel Hill, NC
Integrin Activation

KATHERINE P. PONDER, MD
Washington University School of Medicine, St. Louis, MO
Retroviral Gene Therapy for Hemophilia

WENDELL F. ROSSE, MD
Duke University, Durham, NC
Acquired Hemolytic Anemias

MIGUEL A. SANZ, MD, PHD
Hospital University La Fe, Valencia, Spain
Management of Acute Promyelocytic Leukemia

WENDY STOCK, MD
University of Chicago, Chicago, IL
Clinical Significance of Minimal Residual Disease Monitoring in Leukemia

MICHAEL THIRMAN, MD
University of Chicago, Chicago, IL
MLL-Associated Leukemia

GARY VAN ZANT, PHD
Markey Cancer Center, Lexington, KY
Stem Cells: Integrity During Life-Long Hematopoiesis

Sunday, December 11, 6:30 – 7:30 am

MONICA BESSLER, MD, PHD
Washington University Medical School, St. Louis, MO
Short Telomeres and TERC Gene Mutations in Aplastic Anemias, MDS, PNH, and Other Stem Cell Disorders

SMITA BHATIA, MD, MPH
City of Hope National Medical Center, Duarte, CA
Long-Term Outcomes in Childhood Cancer Survivors

NELSON J. CHAO, MD
Duke University, Durham, NC
Cord Blood Transplants

JOSEPH M. CONNORS, MD
British Columbia Cancer Agency and the University of British Columbia, Vancouver, British Columbia, Canada
Hodgkin Lymphoma in Adults

MELODY J. CUNNINGHAM, MD
Children's Hospital Boston, Boston, MA
Evaluation and Management of Thalassemia

MARY E.D. FLOWERS, MD
Fred Hutchinson Cancer Research Center, Seattle, WA
Long-Term Follow-Up and Chronic Graft-Versus-Host Disease After Transplant

STEVEN GRANT, MD
Virginia Commonwealth University, Richmond, VA
New Targeted Therapies in Leukemia

STEPHANIE A. GREGORY, MD
Rush University Medical Center, Rush University, Chicago, IL
Therapeutic Approaches to Follicular NHL

MELISSA M. HUDSON, MD
St. Jude Children's Research Hospital, Memphis, TN
Risk-Adapted Therapy for Pediatric Hodgkin Lymphoma

NIGEL S. KEY, MD
University of Minnesota Medical School, Minneapolis, MN
New Anticoagulants

RICHARD A. LARSON, MD
University of Chicago, Chicago, IL
Acute Lymphoblastic Leukemia in Adults

STEPHEN PETERSDORF, MD
Seattle Cancer Care Alliance, Seattle, WA
Acute Leukemia in the Elderly

OLIVER W. PRESS, MD, PHD
Fred Hutchinson Cancer Research Center, Seattle, WA
New Treatments for Non-Hodgkin Lymphoma

JERALD RADICH, MD
Fred Hutchinson Cancer Research Center, Seattle, WA
CML – The Significance of Minimal Residual Disease

JACOB RAND, MD
Montefiore Medical Center, Bronx, NY
The Antiphospholipid Syndrome

MARY V. RELLING, PHARMD
St. Jude Children's Research Hospital, Memphis, TN
Pharmacogenomics of ALL

STANLEY L. SCHRIER, MD
Stanford University School of Medicine, Stanford, CA
How to Evaluate Anemia in 2005

DAVID A. SEARS, MD
Baylor College of Medicine, Houston, TX
Evaluation and Management of Sickle Cell Disease in Adults

ARTHUR R. THOMPSON, MD, PHD
Puget Sound Blood Center, Seattle, WA
Management of Hemophilia

JAMES W. VARDIMAN, MD
University of Chicago, Chicago, IL
WHO Classification of Leukemia/MDS/MPD

THEODORE E. WARKENTIN, MD
Hamilton Health Sciences, Hamilton General Hospital, Hamilton, Ontario, Canada
Heparin-Induced Thrombosis

HOWARD J. WEINSTEIN, MD
Massachusetts General Hospital for Children, Boston, MA
Non-Hodgkin Lymphoma in Children

NEAL S. YOUNG, MD
National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD
Bone Marrow Failure